PHIA Koninklijke Philips N.V.

Philips’ Future Health Index 2020 report reveals new insights into younger doctors’ commitment to improving healthcare during COVID-19

Philips’ Future Health Index 2020 report reveals new insights into younger doctors’ commitment to improving healthcare during COVID-19



September 8, 2020

  • 61% of younger doctors ranked telehealth as the digital health technology that would have most improved their experiences during COVID-19, overtaking artificial intelligence (AI) (53%)
  • 47% of younger doctors reported greater appreciation from patients; 44% experienced greater collaboration with colleagues across different skill sets
  • Only 9% of younger doctors surveyed are more likely to leave medicine as a result of their experiences during COVID-19, while over one third (38%) are more likely to stay

Amsterdam, The Netherlands –  (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the results of its latest piece of Future Health Index (FHI) 2020 research. The  survey supplements the main FHI 2020 report, capturing feedback from 500 doctors under the age of 40 in five countries: the United States of America, China, Singapore, France and Germany. The findings reveal how the COVID-19 pandemic has affected the attitudes and experiences of younger doctors, and how they believe the healthcare industry should change in response.

“Healthcare professionals, including the younger generation, have experienced unprecedented levels of stress and were often faced with limited resources in recent months. We must acknowledge the heroic sacrifices that frontline healthcare professionals have endured in the fight against COVID-19. We owe it to them to listen to their voices as we consider the future of the healthcare industry,” said Jan Kimpen, Chief Medical Officer, Royal Philips. “Our FHI Insights survey reveals that despite the challenges they’ve faced, younger doctors are as committed as ever to their vocation. The research spotlights how young doctors perceive change, and is relevant to leaders focused on reshaping how healthcare is being organized and delivered.”

Telehealth overtakes AI in the eyes of younger doctors

The COVID-19 pandemic has prompted younger doctors to change their attitudes to the relative benefits of different health technologies. It has led to a shift in priorities, with younger doctors recognizing the immediate value of telehealth. Before the pandemic, 60% of younger healthcare professionals ranked AI as the top digital health technology that would most improve their work satisfaction, with 39% identifying telehealth as the top technology. 61% of younger doctors now rank telehealth as the digital health technology that would have most improved their experiences at this time, with AI falling to 53%.

Younger doctors surveyed believed that there is room for improvement in how these technologies are used in everyday practice. When asked what would have helped them leverage the health data available to them during the height of the pandemic, nearly half (47%) of younger doctors pointed to better integration of healthcare data between hospitals/practices and between different IT systems or electronic medical records.

Younger doctors want more digital technology

For many younger doctors, working through COVID-19 has shown what a more technologically forward-thinking workplace could look like, with 44% reporting the pandemic exposed them to new ways of using digital health technologies.

As the healthcare sector prepares for the future, many younger doctors hope these advancements will become permanent fixtures of their post-COVID-19 workplace environments. When asked what changes in healthcare they most hoped would become outlast the pandemic, younger doctors ranked exposure to new types of digital health technologies (29%), new ways to use digital health technologies (29%), greater appreciation from patients (29%), and accelerated availability of digital health technologies (28%) as their top responses. 

Many younger doctors are more committed than ever to their careers

The pandemic is presenting healthcare professionals with even greater workplace hardships and moral dilemmas, which are very likely to exacerbate existing levels of burnout and related mental health problems [1]. However, according to the FHI 2020 Insights survey, many younger doctors (38%) say they are more likely to stay in medicine as a result of their experiences working during COVID-19. Most (53%) said COVID-19 had no effect on them wanting to stay in or leave the profession, and only 9% said they were more likely to leave the profession.

Many younger doctors also reported changes in their day-to-day work during the pandemic, which could lead to increased career and personal satisfaction. 47% reported greater appreciation from patients, while 44% experienced greater collaboration with colleagues across different skill sets. Younger doctors in China stood out by reporting a deeper feeling of purpose at work (70%) since the onset of COVID-19.

Since 2016, Philips has conducted original research to help determine the readiness of countries to address global health challenges and build efficient and effective healthcare systems. For details on the  and to access the 2020 report in its entirety, including the FHI Insights: COVID-19 and Young Healthcare Professionals research, visit the  site.

[1] National Academy of Medicine:

Research methodology

The Future Health Index Insights: COVID-19 and Younger Healthcare Professionals survey was fielded from June 19 to July 30, 2020 in 5 countries (China, France, Germany, Singapore and the United States of America) in their native language. The survey was conducted online and offline (as relevant to the needs of each country) with a sample size of 100 per country for doctors under 40 years old, who have completed their first medical degree. The survey length was approximately 10 minutes. The total sample from the survey includes 500 doctors under 40 years old.

For further information, please contact: 

Kathy O’Reilly 

Philips Global Press Office 

Tel. :   

E-mail :  

Twitter:

Joost Maltha

Philips Global Press Office

Tel. : 6

E-mail :

Twitter:

About Royal Philips 

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries. News about Philips can be found at .

 

Attachment

EN
08/09/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips announces 5,000th Zenition mobile C-arm system installation, a...

Philips announces 5,000th Zenition mobile C-arm system installation, advancing access to high-quality, efficient surgical and interventional care worldwide October 8, 2025 Global adoption milestone underscores innovation in mobile C-arm surgical and interventional imaging, with more than 15 million patients treated in 170+ countries every year Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the 5,000th installation of its Philips Zenition mobile surgery imaging system at Kolín Regional Hospital in the Czech Republic. Since its la...

 PRESS RELEASE

Philips unveils latest CT and MR innovations in radiation therapy, adv...

Philips unveils latest CT and MR innovations in radiation therapy, advancing precision cancer care at ASTRO 2025 September 26, 2025 New Rembra RT and Areta RT [1] CT platforms drive accuracy and efficiency in radiation therapy with advanced workflows and long-term valuePhilips debuts helium-free [2] BlueSeal RT 1.5T 70cm MR system with AI-powered SmartSpeed Precise, expanding its leadership in sustainable MR for radiation oncology Amsterdam, the Netherlands – At the American Society for Radiation Oncology () 2025 Annual Meeting, (NYSE: PHG, AEX: PHIA), a global leader in health technolog...

 PRESS RELEASE

Philips joins Optum Healthcare’s network as a preferred provider in th...

Philips joins Optum Healthcare’s network as a preferred provider in the USA September 25, 2025 Philips’ ambulatory and diagnostic solutions and services are now available to 3.4 million Optum policyholders for enhanced outpatient cardiac monitoring Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has entered a national partnership in the USA with Optum Healthcare. The inclusion of Philips’ (MCOT) and Philips Extended Holter (ePatch) in the network is designed to enable earlier detection of cardiac conditions and timely cli...

 PRESS RELEASE

Philips intends to extend maturity of forward purchases of 4 million s...

Philips intends to extend maturity of forward purchases of 4 million shares for long-term incentive plans September 15, 2025 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA) announces today that it intends to extend the settlement of two forward contracts for 2 million long-term incentive plans shares each as part of the share repurchase program on June 14, 2023. The planned extension will postpone the original maturity dates in Q4 2025 by one year to a new maturity date in Q4 2026. Further details will be available via this . For further information, please contact:Michael FuchsPhil...

 PRESS RELEASE

Philips and Masimo announce innovation partnership to advance access t...

Philips and Masimo announce innovation partnership to advance access to patient monitoring measurement technologies September 11, 2025 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, and (NASDAQ: MASI) today announced that the two companies have renewed their multi-year strategic collaboration, marking a fresh chapter in their long-standing partnership. With a shared commitment to innovation and expanding access to high-quality, connected care, the two companies are taking a bold new approach in accelerating the development and delivery of next-...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch